Global Cardiovascular Diseases are Responsible for Around 15 mn Deaths Every Year

Date: 2015-10-16

A cardiovascular disease (CVD) is a disorder related to blood vessels and the heart. Stroke, atherosclerosis, peripheral artery disease, thrombosis, and coronary artery disease are some of the most common cardiovascular diseases. Cardiovascular diseases are among the deadliest diseases in the world. Obesity, smoking, unhealthy lifestyle, high cholesterol, and excess intake of alcohol are some of the causes of and factors associated with cardiovascular diseases. As per the World Health Organization, cardiovascular diseases are responsible for around 15 mn deaths every year, globally. The increasing incidence of cardiovascular diseases will drive the global cardiovascular disease drug market during the period from 2015 to 2023. 
Increasing Cases of Heart Attacks in North America to Boost Global CVD Market
By geography, the global cardiovascular disease drug market is divided into regions such as Latin America, Asia Pacific, North America, Europe, and Rest of the World. In 2013, the North America cardiovascular disease drug market dominated the global cardiovascular disease drug market. According to the reports from the Center for Disease Control and Prevention (CDC), in North America, around 610,000 people die every year due to heart diseases. Every year, around 735,000 residents of the U.S. suffer from heart attacks. Increasing number of heart attacks and other cardiovascular diseases in North America will propel the demand for cardiovascular medicines and treatments in this region during the forecast period. The Asia Pacific cardiovascular disease drug market is predicted to record the fastest growth due to the recent increase in the number of elderly people and increase in awareness about cardiovascular diseases, their debilitating effect on one’s life, and their treatment.   
Some of the leading companies in the global cardiovascular disease drug market are AstraZeneca Plc, Sanofi S.A., Daiichi Sankyo Company Limited, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., United Therapeutics Corporation, Roche Holding AG, Pfizer, Inc., Merck & Co., Novartis AG, Boehringer Ingelheim GmbH, Johnson & Johnson, Actelion Pharmaceuticals Ltd., and Bayer AG. 

Contact With Us
Join templatemonster at google+
Customized Research
Request Sample